Tech Company Financing Transactions
eFFECTOR Therapeutics Funding Round
eFFECTOR Therapeutics, based in San Diego, raised $16.2 million from private investors.
Transaction Overview
Company Name
Announced On
6/8/2023
Transaction Type
Venture Equity
Amount
$16,200,000
Round
Undisclosed
Investors
Proceeds Purpose
The Company intends to use the net proceeds from the offerings, together with its existing cash and cash equivalents and short-term investments, for general corporate and working capital purposes, including funding our research and development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11180 Roselle St.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve Worland
Chief Financial Officer
Alana McNulty
VP - R & D
Siegfried Reich
Browse more venture capital transactions:
Prev: 6/8/2023: Kate Therapeutics venture capital transaction
Next: 6/8/2023: Monster API venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs